Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Shu Zhou 1 Article
Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Lei Wang, Zheng Wu, Dehuan Xie, Ruifang Zeng, Wanqin Cheng, Jiang Hu, Shaomin Huang, Shu Zhou, Rui Zhong, Yong Su
Cancer Res Treat. 2019;51(2):685-695.   Published online August 13, 2018
DOI: https://doi.org/10.4143/crt.2018.250
AbstractAbstract PDFPubReaderePub
Purpose
This study aims to investigate the feasibility of contouring target volume according to residual tumor and decreasing the dose to the tumor regression field after induction chemotherapy (IC) in locoregionally advanced nasopharyngeal carcinoma (NPC).
Materials and Methods
From August 2009 to August 2013, patients with stage III–IVB NPC were treated with IC and concurrent chemoradiotherapy. Gross tumor volume of nasopharynx (GTVnx)–residual and gross tumor volume of cervical lymph node (GTVnd)–residual were contoured according to post-IC residual primary tumor and any N+ disease, respectively. The tumor regression field was included in CTVnx1/CTVnd1 and prescribed a dose of 60 Gy. Outcomes and toxicities of all patients were evaluated.
Results
A total of 57 patients were enrolled. At a median follow-up of 68 months, three cases displayed locoregional recurrence and one case showed both distant metastasis and locoregional recurrence. All locoregional recurrences were in the GTVnx-residual/GTVnd-residual and in-field. The 5-year overall, locoregional relapse-free, distant metastasis-free, and progression-free survival rates were 82.2%, 87.7%, 85.8% and 80.3%, respectively.
Conclusion
After IC, contouring of GTVnx-residual/GTVnd-residual as residual tumor volume and distribution 60 Gy ofradiation dose to the tumorregression field may be feasible and need further investigation.

Citations

Citations to this article as recorded by  
  • Recurrent Patterns in Patients With Nasopharyngeal Caricinoma and Risks Leading to Inaccurate Delineation in Marginal Failure in the Era of Intensity‐Modulated Radiotherapy
    Shu Zhang, Ni Zeng, Jiangping Yang, Jiaqi Han, Jinlan He, Baofeng Duan, Xiaoqiang Chen, Xiaofang Gou, Fubin Zhu, Huizhen Liu, Ming Zeng, Di Yan, Nianyong Chen
    Head & Neck.2024;[Epub]     CrossRef
  • Post‐induction lymph node delineation in nasopharyngeal cancer: A single‐center experience
    Sezin Yuce Sari, Ecem Yigit, Gozde Yazici, Ibrahim Halil Gullu, Sercan Aksoy, Gokhan Ozyigit, Mustafa Cengiz
    Head & Neck.2023; 45(3): 612.     CrossRef
  • Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma
    Qian Chen, Liangfang Shen, Shan Li
    European Archives of Oto-Rhino-Laryngology.2023; 280(5): 2497.     CrossRef
  • Characteristics of local extension based on tumor distribution in nasopharyngeal carcinoma and proposed clinical target volume delineation
    Zheng Wu, Bin Qi, Fei-Fei Lin, Lin Zhang, Qian He, Fei-Ping Li, Hui Wang, Ya-Qian Han, Wen-Jing Yin
    Radiotherapy and Oncology.2023; 183: 109595.     CrossRef
  • Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
    Ying Li, Jianping Bi, Guoliang Pi, Hanping He, Yanping Li, Dandan Zheng, Zecheng Wei, Guang Han
    Cancer Medicine.2023; 12(8): 9449.     CrossRef
  • Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer
    Elham Rahimy, Michael F. Gensheimer, Beth Beadle, Quynh-Thu Le
    Seminars in Radiation Oncology.2023; 33(3): 336.     CrossRef
  • Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study
    Ya-Nan Jin, Zhao-Hui Ruan, Wan-Wei Cao, Lin Yang, Wei Yao, Xiao-Feng Pei, Wang-Jian Zhang, Tia Marks, Ji-Jin Yao, Liang-Ping Xia
    Journal of Cancer Research and Clinical Oncology.2023; 149(13): 11929.     CrossRef
  • Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China
    Xiate Zhou, Jian Zhu, Chao Zhou, Wei Wang, Weijun Ding, Meng Chen, Kuifei Chen, Shuling Li, Xiaofeng Chen, Haihua Yang
    Radiation Oncology.2023;[Epub]     CrossRef
  • Clinical target volume design of postoperative intensity-modulated radiotherapy for major salivary gland tumours according to surgical principles: an innovative method
    Shaowen Lyu, Zheng Wu, Dehuan Xie, Zhiqing Long, Rui Zhong, Wang Lei, Wanqin Cheng, Jiang Hu, Xuekui Liu, Chuanmiao Xie, Yong Su
    Journal of Cancer Research and Clinical Oncology.2022; 148(4): 921.     CrossRef
  • Local control and failure patterns after intensity modulated radiotherapy with reduced target volume delineation after induction chemotherapy for patients with T4 nasopharyngeal carcinoma
    Fang-Fang Kong, Meng-Shan Ni, Rui-Ping Zhai, Hong-Mei Ying, Chao-Su Hu
    Translational Oncology.2022; 16: 101324.     CrossRef
  • Tumor factors associated with in‐field failure for nasopharyngeal carcinoma after intensity‐modulated radiotherapy
    Xixi Liu, Bian Wu, Jing Huang, You Qin, Zhanjie Zhang, Liangliang Shi, Xiaohua Hong, Qian Ding, Gang Peng, Kunyu Yang
    Head & Neck.2022; 44(4): 876.     CrossRef
  • Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma
    Qian Chen, Shan Li
    The Laryngoscope.2022; 132(12): 2379.     CrossRef
  • Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary
    De-Huan Xie, Zheng Wu, Wang-Zhong Li, Wan-Qin Cheng, Ya-Lan Tao, Lei Wang, Shao-Wen Lv, Fei-Fei Lin, Nian-Ji Cui, Chong Zhao, Jun Ma, Shao-Min Huang, Tai-Xiang Lu, Ya-Qian Han, Yong Su
    Journal of Cancer Research and Clinical Oncology.2022; 148(8): 1931.     CrossRef
  • Volumetric modulated arc therapy versus tomotherapy for late T-stage nasopharyngeal carcinoma
    Qian Chen, Lingwei Tang, Zhe Zhu, Liangfang Shen, Shan Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging
    Xingxing Yuan, Chao Yan, Shiyi Peng, Zhiping Chen, Tianzhu Lu, Qiaoying Gong, Yang Qiu, Wenming Xiong, Fenghua Ao, Guoqing Li, Jingao Li, Ziwei Tu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma
    Fen Xue, Dan Ou, Xiaomin Ou, Xin Zhou, Chaosu Hu, Xiayun He
    Oral Oncology.2022; 134: 106139.     CrossRef
  • Is Surgery an Inevitable Treatment for Advanced Salivary Lymphoepithelial Carcinoma? Three Case Reports
    Shaowen Lv, Dehuan Xie, Zheng Wu, Lei Wang, Yong Su
    Ear, Nose & Throat Journal.2021; 100(9): NP402.     CrossRef
  • The change in tumor volume after induction chemotherapy with docetaxel plus cisplatin in 259 nasopharyngeal carcinoma patients
    Shan Li, Liangfang Shen
    European Archives of Oto-Rhino-Laryngology.2021; 278(8): 3027.     CrossRef
  • Extensive pelvic and abdominal lymphadenopathy with hepatosplenomegaly treated with radiotherapy—A case report
    Sahil Mittal, ShaikhA Hussain, RahulV. C Tiwari, AjithB Poovathingal, BPadma Priya, Rishabh Bhanot, Heena Tiwari
    Journal of Family Medicine and Primary Care.2020; 9(2): 1215.     CrossRef
  • Nutritional outcomes after radiotherapy target volume reduction for nasopharyngeal cancer: a Phase III trial
    Li Xiang, Jin-Feng Rong, Hao-Wen Pang, Huai-Lin He, Yue Chen, Jing-Bo Wu, Yong-Sheng Wang
    Future Oncology.2020; 16(9): 427.     CrossRef
  • Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
    Lachlan McDowell, June Corry, Jolie Ringash, Danny Rischin
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Impact of tumor volume enlargement after induction chemotherapy on subsequent radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity‐score matching analysis
    Shan Li, Liangfang Shen
    Cancer Medicine.2020; 9(23): 8832.     CrossRef
  • Target delineation and dose prescription of adaptive replanning intensity‐modulated radiotherapy for nasopharyngeal carcinoma
    Dehuan Xie, Wanqin Cheng, Shaowen Lv, Rui Zhong, Lei Wang, Jiang Hu, Mingli Wang, Shaomin Huang, Yong Su, Yunfei Xia
    Cancer Communications.2019; 39(1): 1.     CrossRef
  • Cisplatin/docetaxel/fluorouracil

    Reactions Weekly.2019; 1753(1): 113.     CrossRef
  • Chemotherapy Potentially Facilitates the Occurrence of Radiation Encephalopathy in Patients With Nasopharyngeal Carcinoma Following Radiotherapy: A Multiparametric Magnetic Resonance Imaging Study
    Youming Zhang, Xiaoping Yi, Jianming Gao, Li Li, Lizhi Liu, Ting Qiu, Jinlei Zhang, Yuanchao Zhang, Weihua Liao
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • 8,404 View
  • 241 Download
  • 23 Web of Science
  • 25 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP